ExodusPoint Capital Management’s Vir Biotechnology VIR Stock Holding History

ExodusPoint Capital Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.23M	Sell	137,059 -40,044	-23%	-$319K	0.01%	938
2025 Q4	$1.07M	Buy	177,103 +17,236	+11%	+$103K	0.01%	975
2025 Q3	$913K	Buy	159,867 +106,874	+202%	+$546K	0.01%	997
2025 Q2	$267K	Buy	+52,993	New	+$284K	﹤0.01%	1264
2025 Q1	–	Sell	-246,833	Closed	-$1.81M	–	2036
2024 Q4	$1.81M	Buy	+246,833	New	+$1.95M	0.01%	751
2024 Q2	–	Sell	-33,607	Closed	-$340K	–	2012
2024 Q1	$340K	Sell	33,607 -104,619	-76%	-$1.07M	﹤0.01%	1227
2023 Q4	$1.39M	Buy	138,226 +57,132	+70%	+$522K	0.01%	689
2023 Q3	$760K	Buy	81,094 +62,720	+341%	+$895K	0.01%	1066
2023 Q2	$451K	Sell	18,374 -20,518	-53%	-$515K	﹤0.01%	1395
2023 Q1	$905K	Buy	38,892 +14,767	+61%	+$378K	0.01%	1173
2022 Q4	$611K	Sell	24,125 -15,243	-39%	-$374K	0.01%	1104
2022 Q3	$759K	Sell	39,368 -5,600	-12%	-$142K	0.01%	1219
2022 Q2	$1.15M	Sell	44,968 -12,359	-22%	-$289K	0.01%	1022
2022 Q1	$1.47M	Buy	+57,327	New	+$1.7M	0.02%	930
2021 Q2	–	Sell	-18,790	Closed	-$963K	–	2840
2021 Q1	$963K	Buy	+18,790	New	+$1.01M	0.01%	939

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

ExodusPoint Capital Management's VIR Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Vir Biotechnology (VIR) stake by 23% in Q1 2026, selling an estimated $319K and leaving 137,059 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #938.

ExodusPoint Capital Management first reported a position in VIR in Q1 2021 and has held it in 15 quarters since. The position peaked at $1.81M in Q4 2024. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

ExodusPoint Capital Management held 137,059 shares of Vir Biotechnology worth $1.23M as of Q1 2026.
ExodusPoint Capital Management sold 40,044 Vir Biotechnology shares in Q1 2026, an estimated $319K.
Vir Biotechnology made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #938 holding.
ExodusPoint Capital Management first reported a position in Vir Biotechnology in Q1 2021 and has held it in 15 quarters since.
ExodusPoint Capital Management's Vir Biotechnology position peaked at $1.81M in Q4 2024.
251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.